A carregar...
Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions
Pancreatic cancer (PC) incidence rates are rapidly increasing in developed countries, with half the patients being metastatic at diagnosis. For decades, fluorouracil, then gemcitabine regimens were the preferred palliative first-line options for fit patients with metastatic PC. FOLFIRINOX (a combina...
Na minha lista:
| Publicado no: | Therap Adv Gastroenterol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5557187/ https://ncbi.nlm.nih.gov/pubmed/28835777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X17713879 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|